Evidence map›Paper›PMID 35654556›Full record

ArticleBiological psychiatry2022

Comorbidities Are Complex: The Dynorphin/Kappa Opioid Receptor System in a Preclinical Model of Stress and Alcohol.

Sineadh M Conway, Ream Al-Hasani

Abstract readComment
PubMed Publisher
In one paragraph

Article in Biological psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Sineadh M ConwayDepartment of Anesthesiology and the Washington University Pain Center, Washington University in St. Louis, St. Louis, Missouri; Center for Clinical Pharmacology, University of Health Sciences and Pharmacy and Washington University School of Medicine, St. Louis, Missouri.
Ream Al-HasaniDepartment of Anesthesiology and the Washington University Pain Center, Washington University in St. Louis, St. Louis, Missouri; Center for Clinical Pharmacology, University of Health Sciences and Pharmacy and Washington University School of Medicine, St. Louis, Missouri. Electronic address: al-hasanir@wustl.edu.

Funding

DEFINING DYNORPHIN-CRF CIRCUITS IN STRESS AND NICOTINE BEHAVIORSR00DA038725 · NIDA · ST. LOUIS COLLEGE OF PHARMACY · PI AL-HASANI, REAM · 2017 to 2019
$747k
Rapid and sensitive in vivo detection of opioid peptidesR21DA048650 · NIDA · ST. LOUIS COLLEGE OF PHARMACY · PI AL-HASANI, REAM · 2019 to 2020
$441k
Understanding dynorphin and dopamine dynamics during fentanyl exposureF32DA053093 · NIDA · WASHINGTON UNIVERSITY · PI CONWAY, SINEADH MARGARET · 2021 to 2022
$136k
NIDA NIH HHS F32 DA053093NIDA NIH HHS R00 DA038725NIDA NIH HHS R21 DA048650
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DynorphinsReceptors, Opioid, kappaComorbidityEthanolNaltrexoneDynorphinsEthanolNaltrexoneReceptors, Opioid, kappa

Identifiers

PMID35654556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.